Tablets India launches probiotic Rescunate
Rescunate has been developed usingprobiotic bifidobacterium breve M-16V from Japanese major Morinaga Milk Industry
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin launches generic Kapvay tabs in the US
The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD)
Cold chain pie to nearly double in five years
Biopharma one of the three sectors to lift growth by 200 bps through fiscal 2022
TAKE Solutions posts financial results for Q3 FY18
EBITDA grew 15.2 per cent in INR Y-o-Y
Stempeutics in agreement with Alkem
Alkem will get the exclusive marketing rights for Stempeucel in India for osteoarthritis with stempeutics manufacturing and…
Strand Life Sciences closes financing led by Quadria Capital
The investment will be utilised to fund the growth and expansion of Strand towards becoming Asia’s leading integrated diagnostics…
DRL recalls 80,000+ bottles of Atorvastatin from US
The product was manufactured at the drug maker’s Srikakulam plant in Andhra Pradesh
Dr Reddy’s Laboratories (DRL) has initiated…
Aurobindo Pharma posts Q3 net profit at Rs 595 cr
Revenues from operations grew by 11 per cent to Rs 4,336 crore
Cipla Q3 profit up 7 per cent to Rs 4 bn
India revenue swells 15 per cent to Rs 16 bn
EMA to shift base from London to Amsterdam
Management board meets in an extraordinary session to discuss EMA’s future premises in Amsterdam